Therapy of cyclophosphamide-induced nasal congestion.
Lipton
J H
JH
D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D001507:Beclomethasone / Q000627:therapeutic use*; D003520:Cyclophosphamide / Q000009:adverse effects*; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects*; D014663:Nasal Decongestants / Q000627:therapeutic use*; D009297:Nasal Mucosa / Q000187:drug effects
D000893:Anti-Inflammatory Agents; D007166:Immunosuppressive Agents; D014663:Nasal Decongestants; D003520:Cyclophosphamide; D001507:Beclomethasone